Related Experiment Video
Updated: May 14, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Clozapine and visuospatial processing in treatment-resistant schizophrenia
Josiane Bourque1, Nadia Lakis, Julie Champagne
1a Fernand-Seguin Research Centre of Louis-H. Lafontaine Hospital , Montreal , Quebec , Canada.
Patients on clozapine showed poorer visuospatial cognition than those on other antipsychotics, suggesting clozapine may not improve nonverbal abilities in treatment-resistant schizophrenia. Further research is needed.
Area of Science:
- Neuroscience
- Psychiatry
- Cognitive Science
Background:
- Clozapine is a primary treatment for treatment-resistant schizophrenia, with some evidence suggesting cognitive benefits.
- However, clozapine's effects on cognition are inconsistent, and underlying mechanisms remain unclear.
- This study investigates cognitive function and neural correlates in schizophrenia patients treated with clozapine versus other antipsychotics.
Purpose of the Study:
- To compare verbal and nonverbal cognitive performance in schizophrenia patients treated with clozapine versus other second-generation antipsychotics.
- To examine differences in neural activity during visuospatial processing between these patient groups and healthy controls.
- To elucidate the relationship between clozapine treatment, treatment resistance, and cognitive function.
Main Methods:
- Schizophrenia patients were divided into clozapine-treated (TR-C) and other atypical antipsychotic-treated (NTR) groups.
- Healthy controls were included for comparison.
- Cognitive function was assessed using verbal and visuospatial tests, with functional magnetic resonance imaging (fMRI) used to analyze brain activity during a mental rotation task.
Main Results:
- Schizophrenia patients generally showed cognitive deficits compared to controls.
- The NTR group outperformed the TR-C group on visuospatial tests like Block Design and Raven's Progressive Matrices.
- fMRI revealed distinct patterns of brain activation during mental rotation: NTR patients showed significant temporal and occipital cortex activation, unlike TR-C patients.
Conclusions:
- Schizophrenia patients treated with atypical antipsychotics other than clozapine demonstrated superior visuospatial processing compared to clozapine-treated patients.
- This difference may stem from treatment resistance or a lack of specific cognitive benefits from clozapine.
- Further research is essential to clarify the interplay between clozapine, treatment resistance, and cognitive outcomes in schizophrenia.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Antipsychotic Drugs: Typical and Atypical Agents
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...

